GB2387781A8 - Particulate materials - Google Patents

Particulate materials

Info

Publication number
GB2387781A8
GB2387781A8 GB0309295A GB0309295A GB2387781A8 GB 2387781 A8 GB2387781 A8 GB 2387781A8 GB 0309295 A GB0309295 A GB 0309295A GB 0309295 A GB0309295 A GB 0309295A GB 2387781 A8 GB2387781 A8 GB 2387781A8
Authority
GB
United Kingdom
Prior art keywords
particulate materials
particulate
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0309295A
Other versions
GB2387781A (en
Inventor
Peter York
Boris Yu Shekunov
Mahboob Ur Rehman
Jane Catherine Feeley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nektar Therapeutics UK Ltd
Original Assignee
Nektar Therapeutics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0209402A external-priority patent/GB0209402D0/en
Priority claimed from GB0210268A external-priority patent/GB0210268D0/en
Priority claimed from GB0211086A external-priority patent/GB0211086D0/en
Priority claimed from GBGB0216562.9A external-priority patent/GB0216562D0/en
Application filed by Nektar Therapeutics UK Ltd filed Critical Nektar Therapeutics UK Ltd
Publication of GB2387781A publication Critical patent/GB2387781A/en
Publication of GB2387781A8 publication Critical patent/GB2387781A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0309295A 2002-04-25 2003-04-24 Particulate materials Withdrawn GB2387781A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0209402A GB0209402D0 (en) 2002-04-25 2002-04-25 Particulate materials
GB0210174A GB0210174D0 (en) 2002-04-25 2002-05-03 Particulate materials
GB0210268A GB0210268D0 (en) 2002-04-25 2002-05-07 Particulate materials
GB0211086A GB0211086D0 (en) 2002-04-25 2002-05-15 Particulate materials
GBGB0216562.9A GB0216562D0 (en) 2002-04-25 2002-07-17 Particulate materials

Publications (2)

Publication Number Publication Date
GB2387781A GB2387781A (en) 2003-10-29
GB2387781A8 true GB2387781A8 (en) 2003-12-17

Family

ID=28795261

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0309295A Withdrawn GB2387781A (en) 2002-04-25 2003-04-24 Particulate materials

Country Status (5)

Country Link
EP (1) EP1501483A2 (en)
AU (1) AU2003226567A1 (en)
CA (1) CA2483218C (en)
GB (1) GB2387781A (en)
WO (1) WO2003090715A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004210399B2 (en) * 2003-02-10 2010-02-18 Bayer Intellectual Property Gmbh Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones
WO2006026502A1 (en) 2004-08-27 2006-03-09 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
AU2009214443B2 (en) 2008-02-13 2013-10-10 Board Of Regents, The University Of Texas System Templated open flocs of anisotropic particles for enhanced pulmonary delivery
GB0921481D0 (en) * 2009-12-08 2010-01-20 Vectura Ltd Process and product
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
CN106170313B (en) 2014-04-28 2020-11-10 菲利普莫里斯生产公司 Flavored nicotine powder inhaler
EP3136894B1 (en) 2014-04-28 2019-07-31 Philip Morris Products S.A. Nicotine powder inhaler
CN107683131B (en) 2015-06-04 2021-09-28 克里蒂泰克公司 Taxane particles and uses thereof
DK3439635T3 (en) 2016-04-04 2021-03-08 Crititech Inc FORMULATIONS FOR THE TREATMENT OF FIXED TUMOR
CN110730679A (en) 2017-06-09 2020-01-24 克里蒂泰克公司 Intracyst injection anti-tumor particle for treating epithelial cyst
US10398646B2 (en) 2017-06-14 2019-09-03 Crititech, Inc. Methods for treating lung disorders
RU2020110399A (en) 2017-10-03 2021-11-09 Крититек, Инк. LOCAL DELIVERY OF ANTITUMOR PARTICLES IN COMBINATION WITH SYSTEM DELIVERY OF IMMUNOTHERAPY AGENTS FOR CANCER TREATMENT
WO2019118393A1 (en) 2017-12-11 2019-06-20 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
DE10129374A1 (en) * 2001-06-20 2003-01-02 Roehm Gmbh Process for the production of moldings with electrically conductive coating and moldings with appropriate coating

Also Published As

Publication number Publication date
CA2483218C (en) 2012-07-10
EP1501483A2 (en) 2005-02-02
AU2003226567A1 (en) 2003-11-10
WO2003090715A3 (en) 2004-03-11
GB2387781A (en) 2003-10-29
WO2003090715A2 (en) 2003-11-06
CA2483218A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
GB2401547B (en) Particulate materials
AU2003293294A8 (en) Uv-stabilised particles
GB2387191B (en) Lightweight particulate materials and uses therefor
EP1494693A4 (en) Cripto-specific antibodies
PL375405A1 (en) Antibodies
TWI346656B (en) Photoactive materials
GB0216562D0 (en) Particulate materials
GB0323055D0 (en) Particulate detector
GB0208742D0 (en) Particulate materials
GB2387781A8 (en) Particulate materials
ZA200704988B (en) Particulate materials
GB0210517D0 (en) Material
GB2411649B (en) Carbonaceous materials
GB0319401D0 (en) Materials
GB0329208D0 (en) Particulate materials
EP1641965A4 (en) Single-crystal-like materials
GB0219091D0 (en) Depositing solid materials
GB0215958D0 (en) Ceramic materials
GB2405334B (en) Particulate materials
GB0209402D0 (en) Particulate materials
GB0210268D0 (en) Particulate materials
GB0211086D0 (en) Particulate materials
GB0209204D0 (en) Particulate materials
GB0226878D0 (en) Antibodies
GB0329964D0 (en) Particulate materials

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)